Clinical Trials Browser

Phase 2 × Recruiting × Renal Pelvis and Ureter Urothelial Carcinoma × Clear all

NCT05775471 2026-02-05

Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

Phase 2 Recruiting

Renal Pelvis and Ureter Urothelial Carcinoma